XLV vs IDNA
YTDYear to date
IDNA wins+45.2 pts
Past year
IDNA wins+45.4 pts
Fee
XLV winslower fee
Yield
XLV wins+0.7 pts
AUM
XLV138.8× more
2–2level
XLV and IDNA · year-to-date · as of Nov 5, 2026 · AUM not scored
IDNA vs S&P 500
YTD$44.15 · +4.0% last sessionDividend-adjusted total return. S&P 500 uses VOO.CompareS&P 500+ Peer avg+ Add a fund
Return1D1M3MYTD ▼1Y3Y5YMAX
Total return+4.0%+8.0%+31.5%+69.3%+78.9%+157.7%−5.6%+90.5%
Peer average+2.7%+8.5%+8.9%+24.4%+33.4%+84.3%+34.0%—
S&P 500 · VOO+1.6%−1.6%0.0%+13.4%+13.5%+91.7%+81.2%+831.3%
iShares IDNA and Vanguard VOO · total return, dividends in · as of Nov 5, 2026
IDNA’s Holdings
TodayMRNAModerna13.3%GMAB.CO6.3%TWST5.6%REGN4.2%BAYN.DE3.8%EXEL3.8%4502.T3.8%RVMD3.6%CAI3.5%MRK3.3%VRTX3.3%ROP.SW3.2%INCY3.2%IOVA3.0%SAN.PA2.8%BNTX2.7%IBRX2.7%GSK.L2.6%IPN.PA2.6%ABCL2.5%IDYA2.3%4528.T1.4%28 more
MRNAModerna13.3%GMAB.CO6.3%TWST5.6%REGN4.2%BAYN.DE3.8%EXEL3.8%4502.T3.8%RVMD3.6%CAI3.5%MRK3.3%VRTX3.3%38 more
BiotechnologyDrug Manufacturers - GeneralDrug Manufacturers - Specialty
iShares IDNA · 50 holdings · tile size = share of the fund · as of Nov 4, 2026
All 39 Health Care ETFs
YTD| # | Trend | |||||||
|---|---|---|---|---|---|---|---|---|
| 1 | XLV | State Street Health Care Select Sector SPDRReadDesk | 0.08% | 1.3% | +24.0% | +24.0% | $49.1B | |
| 2 | VHT | Health CareReadDesk | 0.09% | 1.3% | +23.3% | +23.3% | $19.1B | |
| 3 | XBI | State Street SPDR S&P BiotechReadDesk | 0.35% | 0.3% | +30.6% | +30.6% | $10.6B | |
| 4 | IYH | U.S. HealthcareReadDesk | 0.37% | 1.0% | +23.7% | +23.7% | $4.9B | |
| 5 | IXJ | Global HealthcareReadDesk | 0.38% | 1.2% | +19.7% | +19.7% | $4.7B | |
| 6 | IHI | U.S. Medical DevicesReadDesk | 0.37% | 0.4% | −2.7% | −2.7% | $4.1B | |
| 7 | FHLC | Fidelity MSCI Health CareReadDesk | 0.08% | 1.1% | +23.4% | +23.4% | $3.5B | |
| 8 | ARKG | ARK Genomic RevolutionReadDesk | 0.75% | — | +71.5% | +71.5% | $2.2B | |
| 9 | IHE | U.S. PharmaceuticalsReadDesk | 0.37% | 1.3% | +29.8% | +29.8% | $1.7B | |
| 10 | IHF | U.S. Healthcare ProvidersReadDesk | 0.37% | 0.9% | +27.1% | +27.1% | $1.5B | |
| 11 | PBPH | Portfolio Building Block World Pharma and BiotechReadDesk | 0.13% | 0.1% | +26.0% | +26.0% | $1.2B | |
| 12 | FTXH | First Trust Nasdaq PharmaceuticalsReadDesk | 0.60% | 0.6% | +36.8% | +36.8% | $1.2B | |
| 13 | PPH | VanEck PharmaceuticalReadDesk | 0.36% | 1.8% | +20.4% | +20.4% | $1.2B | |
| 14 | FXH | First Trust Health Care AlphaDEXReadDesk | 0.61% | 0.5% | +26.8% | +26.8% | $1.2B | |
| 15 | PJP | PharmaceuticalsReadDesk | 0.58% | 0.9% | +26.9% | +26.9% | $579M | |
| 16 | BBH | VanEck BiotechReadDesk | 0.35% | 0.4% | +38.2% | +38.2% | $538M |
1–16 of 39Page 1 of 3
Health Care · current AUM · as of Nov 5, 2026
IDNA Payouts by Year
8YLatest payout, Jun 2026
$0.13
a share · twice a year
0.6% yield
0.6% yield
8 years added up
$1.70 a share
$1.70 a share
iShares IDNA · per-share distributions by ex-date · 2019–2026
IDNA’s Peers
YTD| # | Trend | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | XLV | State Street Health Care Select Sector SPDR ETFReadVersus | 0.08% | 1.3% | +3.1% | +24.0% | +33.5% | $49.1B | |
| 2 | VHT | Vanguard Health Care ETFReadVersus | 0.09% | 1.3% | +3.1% | +23.3% | +32.1% | $19.1B | |
| 3 | XBI | State Street SPDR S&P Biotech ETFReadVersus | 0.35% | 0.3% | +2.7% | +30.6% | +45.4% | $10.6B | |
| 4 | IYH | iShares U.S. Healthcare ETFReadVersus | 0.37% | 1.0% | +3.3% | +23.7% | +32.8% | $4.9B | |
| 5 | IXJ | iShares Global Healthcare ETFReadVersus | 0.38% | 1.2% | +3.2% | +19.7% | +28.6% | $4.7B | |
| 6 | IDNA | iShares Genomics Immunology and Healthcare ETFThis fund | 0.47% | 0.6% | +4.0% | +69.3% | +78.9% | $354M |
#2 of 33 this year · #21 cheapest of 39 · sorted by assetsOpen the Sectors table →
IDNA and its peer group · total return · as of Nov 5, 2026
Cards for This View
IDNA’s Top 10 Holdings
Today51.3%of IDNA sits in these 10
2GMAB.CGenmab6.26%
5BAYN.DBayer Ag3.85%
74502.TTakeda Pharmaceutical3.77%
iShares IDNA · weight in the fund · as of Nov 4, 2026
IDNA’s Holdings
TodayMRNAModerna13.3%GMAB.CO6.3%TWST5.6%REGN4.2%BAYN.DE3.8%EXEL3.8%4502.T3.8%RVMD3.6%CAI3.5%MRK3.3%VRTX3.3%ROP.SW3.2%INCY3.2%IOVA3.0%SAN.PA2.8%BNTX2.7%IBRX2.7%GSK.L2.6%IPN.PA2.6%ABCL2.5%IDYA2.3%4528.T1.4%28 more
MRNAModerna13.3%GMAB.CO6.3%TWST5.6%REGN4.2%BAYN.DE3.8%EXEL3.8%4502.T3.8%RVMD3.6%CAI3.5%MRK3.3%VRTX3.3%38 more
BiotechnologyDrug Manufacturers - GeneralDrug Manufacturers - Specialty
iShares IDNA · 50 holdings · tile size = share of the fund · as of Nov 4, 2026
IDNA vs Peer Average
YTDIDNAAvsBPeer average
1D+4.0%+2.7%
1M+8.0%+8.5%
3M+31.5%+8.9%
YTD+69.3%+24.4%
1Y+78.9%+33.4%
3Y+157.7%+84.3%
5Y−5.6%+34.0%
5–2IDNA wins
38 Health care peers · each row scaled to its leader